V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004455 | 10002814 | 1.65 | 68.9 | Neo-adjuvant (N) | 2016-12-23 | 2016-12-30 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | 10527006 | MITOMYCIN INTRAVESICULAR |
| 10004456 | 10002815 | 1.56 | 0 | Palliative (P) | null | 2016-03-29 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 10527031 | TEMOZOLOMIDE |
| 10004457 | 10002816 | 1.65 | 65 | null | 2017-10-03 | 2017-10-08 | AFATINIB | 02 | N | 10527104 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10004458 | 10002817 | 1.6 | 0 | Not known (9) | 2017-08-24 | 2017-09-07 | IBRUTINIB | N | N | 10527115 | AML16 TRIAL |
| 10004459 | 10002818 | 1.66 | 83.5 | Palliative (P) | 2016-04-06 | 2016-04-10 | Methotrexate intrathecal | N | N | 10527131 | PILOT TRIAL |
| 10004460 | 10002819 | 1.7 | 73 | Curative (C) | 2017-10-26 | 2017-10-27 | Sorafenib | 02 | N | 10527298 | CAPECITABINE + STREPTOZOCIN |
| 10004461 | 10002820 | null | 110.3 | Curative (C) | 2017-07-22 | 2017-07-28 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 10527424 | CETUXIMAB + OXALIPLATIN + MDG |
| 10004462 | 10002821 | 1.56 | null | Palliative (P) | 1980-11-12 | 2014-01-01 | Gefitinib: 1 to 2 & 4 onwards | 02 | null | 10527535 | CHLVPP |
| 10004463 | 10002822 | 1.65 | 81.8 | Palliative (P) | 2017-11-06 | 2017-11-06 | Cyclophosphamide oral | N | Y | 10527630 | DHAP |
| 10004464 | 10002823 | 1.74 | 70 | Palliative (P) | 2018-03-11 | 2018-03-11 | Panitumumab | N | N | 10527633 | PANITUMUMAB |
| 10004465 | 10002824 | null | 90 | Palliative (P) | 2017-03-25 | 2017-03-26 | Sunitinib | N | N | 10527658 | FCR |
| 10004466 | 10002825 | 1.77 | 69 | Palliative (P) | 2017-09-09 | 2017-09-18 | CHLVPP | N | N | 10527671 | GEFITINIB |
| 10004467 | 10002826 | null | null | Palliative (P) | 2018-05-04 | 2018-05-27 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 10527738 | LENALIDOMIDE |
| 10004468 | 10002826 | 1.62 | 53 | Curative (C) | 2015-04-03 | 2015-04-03 | TEMOZOLOMIDE | Y | N | 10527738 | AML18 TRIAL |
| 10004469 | 10002827 | null | null | Adjuvant (A) | 2018-08-20 | 2018-08-25 | Cetuximab + Radiotherapy Load | Y | Y | 10527787 | METHOTREXATE |
| 10004470 | 10002828 | 1.86 | 0 | Neo-adjuvant (N) | 2017-11-24 | 2017-12-02 | Mitomycin Intravesical | N | N | 10527851 | ERLOTINIB |
| 10004471 | 10002829 | null | null | Palliative (P) | 2018-04-21 | 2018-04-26 | AFATINIB | N | N | 10527906 | CAPECITABINE + MITOMYCIN + RT |
| 10004472 | 10002830 | 1.81 | 63 | Palliative (P) | 2017-03-18 | 2017-03-23 | OXALIPLATIN | 2 | N | 10527910 | IPILIMUMAB |
| 10004473 | 10002831 | 1.76 | 78 | Palliative (P) | 2016-03-16 | 2016-03-26 | Cyclophos + Dex + Lenalidomide | Y | N | 10527955 | DACARBAZINE |
| 10004474 | 10002832 | 1.68 | 0 | Curative (C) | 2014-11-29 | 2014-12-06 | AML18 PILOT TRIAL | N | N | 10527969 | VEPEMB |
| 10004475 | 10002833 | 1.71 | 100 | Disease modification (D) | 2016-09-04 | 2016-09-05 | GEFITINIB | 02 | N | 10528000 | DA |
| 10004476 | 10002834 | 1.74 | 61.1 | Palliative (P) | 2016-06-15 | 2016-06-16 | Mitomycin Intravesical | N | N | 10528293 | TEMOZOLOMIDE |
| 10004477 | 10002835 | 1.7 | null | Curative (C) | 2017-12-26 | 2017-12-31 | AML18 PILOT TRIAL | N | N | 10528303 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 10004478 | 10002836 | 1.65 | 68.8 | Curative (C) | 2013-05-22 | 2013-06-04 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | 10528385 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10004479 | 10002836 | null | 86.8 | Curative (C) | 2016-12-20 | 2016-12-22 | CISPLATIN + FLUOROURACIL | 2 | N | 10528385 | PAZOPANIB |
| 10004480 | 10002836 | 1.67 | 0 | null | 2014-06-23 | 2014-06-23 | MPV (cycle 1-4) | Y | N | 10528385 | SUNITINIB |
| 10004481 | 10002837 | 1.68 | 0 | Palliative (P) | 2016-05-05 | 2016-05-07 | BORTEZOMIB + THALIDOMIDE | N | N | 10528789 | DABRAFENIB |
| 10004482 | 10002837 | 1.66 | 72 | Palliative (P) | 2014-05-29 | 2014-05-29 | Lomustine | 02 | N | 10528789 | CYTARABINE |
| 10004483 | 10002837 | null | 89.6 | Palliative (P) | 2017-09-02 | 2017-10-01 | Pazopanib | 02 | N | 10528789 | CISPLATIN + FLUOROURACIL |
| 10004484 | 10002837 | 1.72 | 53.45 | Disease modification (D) | 2015-11-08 | 2015-11-20 | CISPLATIN + VINORELBINE + RT | N | N | 10528789 | PAZOPANIB |
| 10004485 | 10002838 | 0 | 58.3 | Palliative (P) | null | 2016-07-26 | Doxorubicin + Ifosfamide | N | N | 10529337 | METHOTREXATE HIGH DOSE + RITUXIMAB |
| 10004486 | 10002839 | 1.62 | 83.6 | Palliative (P) | 2018-02-23 | 2018-02-26 | Temozolomide 150mg/m2 | N | N | 10529750 | EVEROLIMUS |
| 10004487 | 10002840 | 1.63 | 56.8 | Palliative (P) | 2017-03-04 | 2017-03-07 | IPILIMUMAB + NIVOLUMAB | N | N | 10529819 | RCEOP |
| 10004488 | 10002841 | 1.75 | null | Palliative (P) | 2016-02-17 | 2016-02-20 | Cetuximab + Irinotecan (Cycle 1) | N | N | 10529880 | BLEOMYCIN |
| 10004489 | 10002841 | 1.7 | null | Palliative (P) | 2017-08-11 | 2017-08-11 | CAPECITABINE + CISPLATIN + Trastuzumab | N | N | 10529880 | IPILIMUMAB + NIVOLUMAB |
| 10004490 | 10002842 | 1.7 | 57.4 | Palliative (P) | 2014-12-02 | 2014-12-27 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 10530211 | MITOMYCIN INTRAVESICULAR |
| 10004491 | 10002842 | 1.73 | 83.2 | Palliative (P) | 2018-10-14 | 2018-10-22 | Cape+Cisplatin+Trastuzumab Load | 02 | Y | 10530211 | RUXOLITINIB |
| 10004492 | 10002842 | 1.73 | 88 | Curative (C) | 2018-04-22 | 2018-05-07 | Pazopanib | N | N | 10530211 | MITOMYCIN |
| 10004493 | 10002842 | 1.67 | null | Palliative (P) | 2017-04-15 | 2017-04-30 | Ipilimumab | 02 | N | 10530211 | PAZOPANIB |
| 10004494 | 10002842 | null | null | Palliative (P) | 2013-07-30 | 2013-08-05 | Ipilimumab | 02 | N | 10530211 | OCTREOTIDE |
| 10004495 | 10002843 | 1.75 | 69.8 | Palliative (P) | 2018-01-04 | 2018-01-08 | Cyclophosphamide + Docetaxel | 02 | N | 10530539 | SORAFENIB |
| 10004496 | 10002844 | 1.75 | 104.5 | null | 2018-02-06 | 2018-02-25 | Alemtuz+Fludara+Melphalan RIC MUD | N | Y | 10530590 | MPT |
| 10004497 | 10002845 | 0 | 66.4 | Palliative (P) | 2018-06-09 | 2018-06-09 | Cetuximab + Oxaliplatin + MdG Load | N | N | 10530622 | CAPECITABINE + CARBOPLATIN |
| 10004498 | 10002845 | null | 64.2 | Palliative (P) | 2015-02-20 | 2015-02-20 | MELPHALAN | 02 | N | 10530622 | TEMOZOLOMIDE |
| 10004499 | 10002845 | 1.75 | null | Palliative (P) | 2015-10-24 | 2015-10-24 | Folfirinox | N | N | 10530622 | CAPECITABINE + MITOMYCIN |
| 10004500 | 10002846 | null | null | Palliative (P) | 2015-01-05 | 2015-01-10 | CYTARABINE | N | N | 10530720 | AML18 TRIAL |
| 10004501 | 10002846 | 1.66 | 95.7 | null | 2018-08-17 | 2018-08-17 | Lomustine | 02 | null | 10530720 | ECF |
| 10004502 | 10008193 | 1.86 | null | Curative (C) | 2016-01-06 | 2016-02-02 | CARBOPLATIN + RT | 01 | N | 10530929 | CETUXIMAB + IRINOTECAN + MDG |
| 10004503 | 10002847 | 1.6 | null | Disease modification (D) | 2018-10-13 | 2018-11-10 | DABRAFENIB | N | Y | 10530973 | IPILIMUMAB |
| 10004504 | 10002847 | 1.67 | 70.5 | Palliative (P) | 2017-04-20 | 2017-05-06 | Cetuximab + Radiotherapy Maint | 02 | N | 10530973 | DOXORUBICIN EMBOLISATION |